Thierry Lesimple
Impact in
Papers in
- Co-authors
- Luc Thomas (7 shared papers)Karim S. Fizazi (9 shared papers)Yacine Merrouche (8 shared papers)Célèste Lebbé (20 shared papers)Caroline Robert (11 shared papers)Stéphane Culine (4 shared papers)Laurent Mortier (11 shared papers)Jean‐Jacques Grob (9 shared papers)
- Journals
- European Journal of Cancer (14 papers)Annals of Oncology (14 papers)Journal of Clinical Oncology (7 papers)The Lancet Oncology (6 papers)Journal of Neuro-Oncology (5 papers)
- Partner nations
- FranceUnited StatesGermany
In The Last Decade
Thierry Lesimple
146 papers receiving 7.0k citations
Thierry Lesimple's Hit Papers
Peers
Comparison fields: 5 of 116
- Oncology 3.9k
- Genetics 1.0k
- Immunology 940
- Pulmonary and Respiratory Medicine 1.3k
- Cancer Research 565
Countries citing papers authored by Thierry Lesimple
This map shows the geographic impact of Thierry Lesimple's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thierry Lesimple with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thierry Lesimple more than expected).
Fields of papers citing papers by Thierry Lesimple
This network shows the impact of papers produced by Thierry Lesimple. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thierry Lesimple. The network helps show where Thierry Lesimple may publish in the future.
Co-authors
The 25 scholars most cited alongside Thierry Lesimple, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 155 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Adjuvant Dabrafenib plus Trametinib in Stage III BRAF -Mutated Melanoma Hit paper breakdown → | 2017 | 1143 |
| 2 | Dabrafenib plus trametinib in patients with BRAFV600-mutant melanoma brain metastases (COMBI-MB): a multicentre, multicohort, open-label, phase 2 trial Hit paper breakdown → | 2017 | 593 |
| 3 | 2017 | 306 | |
| 4 | 2020 | 303 | |
| 5 | Adjuvant pembrolizumab versus placebo in resected stage III melanoma (EORTC 1325-MG/KEYNOTE-054): distant metastasis-free survival results from a double-blind, randomised, controlled, phase 3 trial Hit paper breakdown → | 2021 | 296 |
| 6 | 2003 | 258 | |
| 7 | Adjuvant and concurrent temozolomide for 1p/19q non-co-deleted anaplastic glioma (CATNON; EORTC study 26053-22054): second interim analysis of a randomised, open-label, phase 3 study Hit paper breakdown → | 2021 | 246 |
| 8 | 2019 | 234 | |
| 9 | 2018 | 201 | |
| 10 | 2012 | 187 | |
| 11 | 2002 | 160 | |
| 12 | 2003 | 128 | |
| 13 | 2003 | 117 | |
| 14 | 1993 | 114 | |
| 15 | 2000 | 103 | |
| 16 | 2003 | 92 | |
| 17 | 2015 | 87 | |
| 18 | 1993 | 82 | |
| 19 | 1997 | 79 | |
| 20 | 2024 | 72 |
About Thierry Lesimple
Thierry Lesimple is a scholar working on Oncology, Genetics, Immunology, Pulmonary and Respiratory Medicine and Molecular Biology, having authored 155 papers that have together received 7.2k indexed citations. Recurring topics across this work include Melanoma and MAPK Pathways (25 papers), Cancer Immunotherapy and Biomarkers (20 papers), Glioma Diagnosis and Treatment (18 papers), Cutaneous Melanoma Detection and Management (17 papers), Immunotherapy and Immune Responses (16 papers), CAR-T cell therapy research (13 papers), Cancer Diagnosis and Treatment (11 papers) and Brain Metastases and Treatment (7 papers). The work is most often cited by research in Oncology (3.9k citations), Genetics (1.0k citations), Immunology (940 citations), Pulmonary and Respiratory Medicine (1.3k citations) and Cancer Research (565 citations). Thierry Lesimple has collaborated with scholars based in France, United States and Germany. Frequent co-authors include Luc Thomas, Karim S. Fizazi, Yacine Merrouche, Célèste Lebbé, Caroline Robert, Stéphane Culine, Laurent Mortier, Jean‐Jacques Grob, Alain H. Lortholary and Sylvie Négrier. Their work appears in journals such as European Journal of Cancer, Annals of Oncology, Journal of Clinical Oncology, The Lancet Oncology and Journal of Neuro-Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.